Phase II study of irinotecan, carboplatin, bevacizumab, and radiation therapy in the treatment of patients with limited stage small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Irinotecan
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 25 Oct 2006 New trial record.